Emergent Biosolutions Inc

NYSE:EBS   4:00:00 PM EDT
-0.38 (-4.65%)
: $7.90 +0.11 (+1.41%)
Earnings Announcements

Health Canada Announces Results Of Emergent Biosolutions Facility Inspection

Published: 11/24/2021 17:22 GMT
Emergent Biosolutions Inc (EBS) - :health Canada Announces Results of Emergent Biosolutions Facility Inspection.
Health Canada - All Three Regulators Found Facility to Be Compliant With Good Manufacturing Practices.
Health Canada - European Medicines Agency and South African Health Products Regulatory Authority Also Participated in This Inspection Remotely.
Health Canada - Compliant Rating Means Janssen to Be Able to Import Their Vaccines Into Canada Made With Drug Substance Manufactured at Emergent's Facility.
Revenue is expected to be $175.12 Million
Adjusted EPS is expected to be -$1.12

Next Quarter Revenue Guidance is expected to be $254.83 Million
Next Quarter EPS Guidance is expected to be -$0.60

More details on our Analysts Page.